AstraZeneca Acquires China Rights to GPC3 Armored CAR-T Therapy
18 Jan 2026 //
PR NEWSWIRE
AbelZeta To Join Panel At 44th J.P. Morgan Healthcare Conference
06 Jan 2026 //
PR NEWSWIRE
AbelZeta to Present Ph1 anti-CD20/BCMA CAR-T Data at ACR 2025
20 Oct 2025 //
PR NEWSWIRE

Market Place
Sourcing Support